Vancouver-based Miraterra has closed a $16 million financing round to scale its AI-driven soil measurement platform. The round was originally structured at $13.9 million but was oversubscribed — a vote of confidence from investors.

At One Ventures led the round, with follow-on financing from Farm Credit Canada (FCC) and additional participation from S2G Investments, the Sitka Foundation, and iSelect. At One Ventures was founded by Tom Chi, a former Head of Experience and founding member at Google X, and focuses on deep-tech startups working to make humanity a net positive to nature.

The raise comes on the heels of Miraterra's acquisition of Trace Genomics' assets in 2025, including intellectual property, analytical tools, and laboratory facilities in Ames, Iowa. Together, the acquisition and new capital will go toward the commercial rollout of Miraterra's next-generation platform and expanding its measurement scope beyond soil to plants and food.

To understand the appeal, it helps to understand what Miraterra is actually doing. Conventional soil testing typically measures one dimension at a time — chemical, physical, or biological — which limits accuracy and the usefulness of the data. Miraterra's platform integrates all three into a single measurement system, combining laser-based Raman spectroscopy, DNA sequencing, satellite sensing, and AI.

The centrepiece is the Digitizer, a device that uses Raman spectroscopy, machine learning, and AI to measure soil and food. Paired with a proprietary soil DNA library, the system reads land from above using geospatial tools, measures chemical and physical properties on the ground, and processes the results into insights for farmers, food producers, and policymakers.

Tom Chi, founding partner at At One Ventures, says the integration of multiple measurement dimensions is what sets Miraterra apart. "Most tools only measure one of those dimensions at a time, which limits both accuracy and usefulness. What Miraterra is doing differently is integrating all three — mineralogical, hydrological, and biological — into a single, scalable measurement platform."

CEO Nate Kelly says the Trace Genomics acquisition is central to the company's global ambitions. "By uniting Trace's technology, lab, and talented team with Miraterra, we're accelerating our mission to deliver soil-to-table measurement worldwide. The acquisition brings a pioneering U.S. soil biology company north, establishing Canada as a global hub for soil DNA sequencing and biological data innovation."

The raise also comes at a moment when soil measurement has become a more urgent policy concern. In Canada, Bill S-230, the National Strategy for Soil Health Act, proposes a national soil plan, a soil health advocate, and a governance framework. The bill is currently in committee in the Senate and is expected to move to the House of Commons in the first half of 2026.

Adam Smalley, managing director of FCC Capital, says the crown corporation sees soil health as foundational to the future of Canadian farming. "Miraterra's technology makes high-quality soil and biological data accessible to producers, empowering them to grow healthy crops and continue to put food on tables, both at home and abroad."

Miraterra won the agtech pitch competition at ALL IN 2025 — one of Canada's largest AI conferences. The new capital will also go toward scaling global operations, deepening AI and data science capabilities, and expanding partnerships across the agricultural value chain.